Skip to main navigation
Skip to search
Skip to main content
University of Limerick Home
Home
Profiles
Research units
Research output
Prizes
Activities
Press/Media
Student theses
Search by expertise, name or affiliation
NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy
Negin Parsamanesh
, Maryam Moossavi
, Afsane Bahrami
, Mohammad Fereidouni
,
George Barreto
, Amirhossein Sahebkar
Birjand University of Medical Sciences
Cellular and Molecular Research Center, Birjand University of Medical Sciences
Universidad Javeriana
Universidad Autónoma de Chile
Mashhad University of Medical Sciences
Research output
:
Contribution to journal
›
Review article
›
peer-review
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'NLRP3 inflammasome as a treatment target in atherosclerosis: A focus on statin therapy'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Pharmacology, Toxicology and Pharmaceutical Science
Atherosclerosis
100%
Statin (Protein)
100%
Inflammasome
100%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
66%
Cytokine
16%
Potassium Ion
16%
Antiapoptotic
16%
Hyperlipidemia
16%
Inflammatory Disease
16%
Anti-Inflammatory Drug
16%
Pyrin
16%
Effusion
16%
Nucleotide Binding Oligomerization Domain Like Receptor
16%
Inflammation
16%
Antioxidant
16%
Adenosine Triphosphate
16%
Cathepsin B
16%
Interleukin 18
16%
Cardiovascular Disease
16%
Immunology and Microbiology
NLRP3 Inflammasome
100%
Atherosclerosis
100%
Interleukin-1
16%
Mediator
16%
Proinflammatory Cytokine
16%
Inflammatory Disorder
16%
NOD-like Receptor
16%
Pyrin Domain
16%
Interleukin 18
16%